WO2000007979A3 - Compounds and compositions for delivering active agents - Google Patents
Compounds and compositions for delivering active agents Download PDFInfo
- Publication number
- WO2000007979A3 WO2000007979A3 PCT/US1999/017974 US9917974W WO0007979A3 WO 2000007979 A3 WO2000007979 A3 WO 2000007979A3 US 9917974 W US9917974 W US 9917974W WO 0007979 A3 WO0007979 A3 WO 0007979A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- compounds
- active agents
- delivering active
- delivering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/54—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/58—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/57—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
- C07C309/59—Nitrogen analogues of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
- C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9912975-2A BR9912975A (en) | 1998-08-07 | 1999-08-06 | Compound and compositions for release of active agents, method for obtaining and using them |
CA002339765A CA2339765C (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
IL14093099A IL140930A0 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
EP99940967A EP1102742B1 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
US09/762,067 US6991798B1 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
CNB998094382A CN1313439C (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
NZ509410A NZ509410A (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
JP2000563614A JP4430235B2 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivery of active agents |
DE69931930T DE69931930T2 (en) | 1998-08-07 | 1999-08-06 | COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES |
AU54711/99A AU5471199A (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
HU0103188A HUP0103188A2 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
IL140930A IL140930A (en) | 1998-08-07 | 2001-01-16 | Compounds and compositions for delivering active agents |
HK01108027A HK1036969A1 (en) | 1998-08-07 | 2001-11-14 | Compounds and compositions for delivering active agents |
AU2003261486A AU2003261486B2 (en) | 1998-08-07 | 2003-11-06 | Compounds and compositions for delivering active agents |
US11/173,075 US7186414B2 (en) | 1998-08-07 | 2005-06-30 | Compounds and compositions for delivering active agents |
US11/531,602 US7744910B2 (en) | 1998-08-07 | 2006-09-13 | Compounds and compositions for delivering active agents |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9577898P | 1998-08-07 | 1998-08-07 | |
US9850098P | 1998-08-31 | 1998-08-31 | |
US10836698P | 1998-11-13 | 1998-11-13 | |
US11920799P | 1999-02-05 | 1999-02-05 | |
US60/108,366 | 1999-02-05 | ||
US60/095,778 | 1999-02-05 | ||
US60/098,500 | 1999-02-05 | ||
US60/119,207 | 1999-02-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/762,067 Continuation US6991798B1 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000007979A2 WO2000007979A2 (en) | 2000-02-17 |
WO2000007979A3 true WO2000007979A3 (en) | 2000-05-18 |
Family
ID=27492815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/017974 WO2000007979A2 (en) | 1998-08-07 | 1999-08-06 | Compounds and compositions for delivering active agents |
Country Status (19)
Country | Link |
---|---|
US (2) | US7186414B2 (en) |
EP (1) | EP1102742B1 (en) |
JP (2) | JP4430235B2 (en) |
KR (1) | KR100659753B1 (en) |
CN (1) | CN1313439C (en) |
AT (1) | ATE329897T1 (en) |
AU (1) | AU5471199A (en) |
BR (1) | BR9912975A (en) |
CA (1) | CA2339765C (en) |
CZ (1) | CZ302280B6 (en) |
DE (1) | DE69931930T2 (en) |
ES (1) | ES2267283T3 (en) |
HK (1) | HK1036969A1 (en) |
HU (1) | HUP0103188A2 (en) |
IL (2) | IL140930A0 (en) |
NZ (1) | NZ509410A (en) |
PL (1) | PL212652B1 (en) |
TR (1) | TR200100366T2 (en) |
WO (1) | WO2000007979A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8927015B2 (en) | 2006-04-12 | 2015-01-06 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
US8933022B2 (en) | 2011-03-01 | 2015-01-13 | Jds Therapeutics, Llc | Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
US9119835B2 (en) | 2007-03-13 | 2015-09-01 | JDS Therapeautics, LLC | Methods and compositions for the sustained release of chromium |
US9364502B2 (en) | 2006-06-28 | 2016-06-14 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
US9421170B2 (en) | 2007-06-26 | 2016-08-23 | Jds Therapeutics, Llc | Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610329B2 (en) | 1993-04-22 | 2003-08-26 | Emisphere Technologies Inc. | Compositions for the delivery of antigens |
US6001347A (en) | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6358504B1 (en) * | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6440929B1 (en) | 1998-07-27 | 2002-08-27 | Emisphere Technologies, Inc. | Pulmonary delivery of active agents |
JP4675481B2 (en) | 1998-07-27 | 2011-04-20 | エミスフェアー・テクノロジーズ・インク | Pulmonary delivery of active agents |
US6518036B1 (en) * | 1999-03-17 | 2003-02-11 | Nen Life Science Products, Inc. | Method of permanent fluorescent assay |
AU4216700A (en) | 1999-04-05 | 2000-10-23 | Emisphere Technologies, Inc. | Disodium salts, monohydrates, and ethanol solvates |
WO2001044199A1 (en) * | 1999-12-16 | 2001-06-21 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2001070219A1 (en) * | 2000-03-21 | 2001-09-27 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
WO2002002509A1 (en) * | 2000-06-29 | 2002-01-10 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2002015959A2 (en) * | 2000-08-18 | 2002-02-28 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2002016309A1 (en) | 2000-08-18 | 2002-02-28 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
DE60134245D1 (en) * | 2000-09-06 | 2008-07-10 | Emisphere Tech Inc | (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS |
WO2003045331A2 (en) * | 2001-11-29 | 2003-06-05 | Emisphere Technologies, Inc. | Formulations for oral administration of cromolyn sodium |
EP2272501B1 (en) | 2002-01-09 | 2013-03-20 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
NZ537858A (en) | 2002-07-15 | 2008-04-30 | Myriad Genetics Inc | Compounds, compositions, and methods employing same |
US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
ES2222822B1 (en) * | 2003-07-28 | 2005-12-16 | Laboratorios Farmaceuticos Rovi, S.A. | DIAMIDES OF AMINO ACIDS IN NON-ALFA POSITION USEFUL AS ASSISTANTS FOR THE ADMINISTRATION OF ACTIVE BIOLOGICAL AGENTS. |
MXPA06012841A (en) | 2004-05-06 | 2007-02-15 | Emisphere Tech Inc | Solid dosage form of wetted heparin. |
ES2586423T3 (en) | 2004-05-14 | 2016-10-14 | Emisphere Technologies, Inc. | Aryl ketone compounds and compositions for administering active ingredients |
EP1756039B1 (en) * | 2004-05-14 | 2012-10-17 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
NZ551455A (en) | 2004-05-19 | 2012-03-30 | Emisphere Tech Inc | Acyclovir formulations |
JP4885856B2 (en) | 2004-05-19 | 2012-02-29 | エミスフェアー・テクノロジーズ・インク | Topical cromolyn formulation |
AU2005271526B2 (en) | 2004-08-03 | 2011-12-08 | Emisphere Technologies, Inc. | Antidiabetic oral insulin-biguanide combination |
GB0427600D0 (en) * | 2004-12-16 | 2005-01-19 | Novartis Ag | Organic compounds |
MX2007008082A (en) | 2004-12-29 | 2007-09-05 | Emisphere Tech Inc | Pharmaceutical formulations of gallium salts. |
US8110547B2 (en) | 2005-01-12 | 2012-02-07 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
WO2007011958A2 (en) | 2005-07-15 | 2007-01-25 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
US8613095B2 (en) * | 2006-06-30 | 2013-12-17 | The Invention Science Fund I, Llc | Smart distribution of a malware countermeasure |
WO2007133944A2 (en) | 2006-05-09 | 2007-11-22 | Emisphere Technologies, Inc. | Topical administration of acyclovir |
US9873667B2 (en) | 2006-07-27 | 2018-01-23 | Emisphere Technologies Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
ES2296529B1 (en) * | 2006-08-07 | 2009-04-01 | Laboratorios Farmaceuticos Rovi, S.A. | PHARMACEUTICAL COMPOSITION WITH ABSORPTION PROMOTERS. |
EP2057112B1 (en) | 2006-08-31 | 2018-12-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
JP5985985B2 (en) | 2009-08-03 | 2016-09-06 | エミスフィアー テクノロジーズ インコーポレイテッドEmisphere Technologies,Inc. | Rapid-acting naproxen composition with reduced gastrointestinal effects |
WO2012130193A1 (en) | 2011-03-31 | 2012-10-04 | Zentiva, K.S. | Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration |
EP2850095B1 (en) | 2012-05-17 | 2019-10-09 | RA Pharmaceuticals, Inc. | Peptide and peptidomimetic inhibitors |
ES2813340T3 (en) | 2012-09-21 | 2021-03-23 | Intensity Therapeutics Inc | Cancer treatment method |
PT3104853T (en) | 2014-02-10 | 2020-01-14 | Respivant Sciences Gmbh | Mast cell stabilizers treatment for systemic disorders |
HUE049323T2 (en) | 2014-02-10 | 2020-09-28 | Respivant Sciences Gmbh | Mast cell stabilizers for lung disease treatment |
BR112016029076B1 (en) | 2014-06-12 | 2024-02-15 | Ra Pharmaceuticals, Inc | POLYPEPTIDE AND COMPOSITION COMPRISING THE SAME FOR INHIBITING CLEAVAGE OF C5 IN A CELLULAR SYSTEM |
SI3250230T1 (en) | 2015-01-28 | 2022-01-31 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
EP3331522A1 (en) | 2015-08-07 | 2018-06-13 | Patara Pharma LLC | Methods for the treatment of mast cell related disorders with mast cell stabilizers |
WO2017027402A1 (en) | 2015-08-07 | 2017-02-16 | Patara Pharma, LLC | Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders |
AU2016370210A1 (en) | 2015-12-16 | 2018-06-21 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
AU2017217466A1 (en) | 2016-02-11 | 2018-08-23 | Nutrition 21, Llc | Chromium containing compositions for improving health and fitness |
US10954287B2 (en) | 2016-04-15 | 2021-03-23 | Ra Pharmaceuticals, Inc. | Ras binding peptides and methods of use |
AU2017321495A1 (en) | 2016-08-31 | 2019-03-21 | Respivant Sciences Gmbh | Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis |
EP3522983A4 (en) | 2016-10-07 | 2020-06-03 | Respivant Sciences GmbH | Cromolyn compositions for treatment of pulmonary fibrosis |
CN110087668A (en) | 2016-12-07 | 2019-08-02 | Ra制药公司 | The regulator of complement activity |
TW202114985A (en) * | 2019-06-28 | 2021-04-16 | 日商小野藥品工業股份有限公司 | Ep antagonist |
CN111269193B (en) * | 2020-04-02 | 2022-05-24 | 湖南海利常德农药化工有限公司 | Preparation method of benzo [ e ] [1,3] oxazine-2, 4-dione |
CN114163426B (en) * | 2020-09-10 | 2024-03-19 | 上海爱博医药科技有限公司 | Benzo oxygen-containing heterocyclic compound and medical application thereof |
CN116444392A (en) * | 2022-01-06 | 2023-07-18 | 中国药科大学 | Polypeptide protein medicine oral absorption promoter and preparation method and application thereof |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012475A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Active agent transport systems |
WO1996012473A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1996012474A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
WO1996021464A1 (en) * | 1995-01-13 | 1996-07-18 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
WO1996030036A1 (en) * | 1995-03-31 | 1996-10-03 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1997036480A1 (en) * | 1996-03-29 | 1997-10-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1998021951A1 (en) * | 1996-11-18 | 1998-05-28 | Emisphere Technologies, Inc. | Methods and compositions for inducing oral tolerance in mammals |
WO1998034632A1 (en) * | 1997-02-07 | 1998-08-13 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1998049135A1 (en) * | 1997-04-30 | 1998-11-05 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1999016427A1 (en) * | 1997-09-29 | 1999-04-08 | Emisphere Technologies, Inc. | Active agent transport systems |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR985340A (en) | 1949-04-29 | 1951-07-17 | Chabas Et Besson Soc | Tipper on various vehicles with hydraulic cylinders actuated by pedal compressor |
FR4446M (en) | 1964-08-17 | 1966-11-02 | Francia Farma | Drug with anti-inflammatory, analgesic and spasmolytic action based on derivatives of y- (orthohydroxy-benzamido) -butyric acid. |
US3489793A (en) * | 1966-05-16 | 1970-01-13 | Francia Formaceutici S R L | New benzamido butyric acid derivatives |
ES369853A1 (en) | 1969-07-24 | 1971-07-16 | Bama S A Lab | Procedure for the obtaining of derivatives of the epsilon-amino-caproico acid. (Machine-translation by Google Translate, not legally binding) |
GB1512509A (en) | 1974-05-23 | 1978-06-01 | Shell Bv | Fungicides |
US4061466A (en) * | 1974-10-16 | 1977-12-06 | Ingvar Gosta Holger Sjoholm | Biologically active composition and the use thereof |
DE2517229A1 (en) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | PHENYLALKYLCARBONIC ACID DERIVATIVES AND PROCESS FOR THEIR PRODUCTION |
CA1077842A (en) * | 1975-10-09 | 1980-05-20 | Minnesota Mining And Manufacturing Company | Albumin medicament carrier system |
DE2834051A1 (en) | 1978-08-03 | 1980-02-21 | Dynamit Nobel Ag | METHOD FOR PRODUCING TEREPHTHAL, ISOPHTHAL AND PHTHALDIALDEHYDE |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
US4442090A (en) * | 1980-11-09 | 1984-04-10 | Kyoto Yakuhin Kogyo Kabushiki Kaisha | Absorption-promoting compounds, compositions thereof with pharmaceuticals and/or bases for rectal administration and method of use |
US4900730A (en) * | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
GB2092136B (en) * | 1981-01-17 | 1985-06-05 | Mitsui Toatsu Chemicals | Production of n-substituted amide compounds |
JPS58140026A (en) * | 1982-01-14 | 1983-08-19 | Toyo Jozo Co Ltd | Pharmaceutical having improved absorbability |
FR2509175B1 (en) | 1981-03-06 | 1987-01-16 | Toyo Jozo Kk | THERAPEUTIC PREPARATION HAVING EXCELLENT ABSORPTION PROPERTIES |
US4757066A (en) * | 1984-10-15 | 1988-07-12 | Sankyo Company Limited | Composition containing a penem or carbapenem antibiotic and the use of the same |
US4689182A (en) | 1985-12-20 | 1987-08-25 | Warner-Lambert Company | Benzoic acid and benzoic acid ester derivatives having anti-inflammatory and analgesic activity |
LU86258A1 (en) * | 1986-01-21 | 1987-09-03 | Rech Dermatologiques C I R D S | BENZAMIDO AROMATIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS |
USRE35862E (en) * | 1986-08-18 | 1998-07-28 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
EP0318512B1 (en) | 1986-08-18 | 1998-06-17 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents |
US4895725A (en) | 1987-08-24 | 1990-01-23 | Clinical Technologies Associates, Inc. | Microencapsulation of fish oil |
FR2636238B1 (en) * | 1988-09-14 | 1994-01-21 | Morelle Jean | NEW ANTISUDORAL COMPOSITIONS |
US4983402A (en) * | 1989-02-24 | 1991-01-08 | Clinical Technologies Associates, Inc. | Orally administerable ANF |
US4976968A (en) * | 1989-02-24 | 1990-12-11 | Clinical Technologies Associates, Inc. | Anhydrous delivery systems for pharmacological agents |
US5693338A (en) * | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5443841A (en) * | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
US5578323A (en) * | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
US6099856A (en) * | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
US5447728A (en) * | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US5541155A (en) * | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5451410A (en) * | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
US5338837A (en) * | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
US5811127A (en) * | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5792451A (en) * | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
HU211995B (en) * | 1992-06-30 | 1996-01-29 | Gyogyszerkutato Intezet | Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them |
US5583020A (en) | 1992-11-24 | 1996-12-10 | Ribozyme Pharmaceuticals, Inc. | Permeability enhancers for negatively charged polynucleotides |
US5401516A (en) * | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
IL109403A0 (en) * | 1993-04-22 | 1994-07-31 | Emisphere Tech Inc | Oral drug delivery compositions and methods |
US6610329B2 (en) * | 1993-04-22 | 2003-08-26 | Emisphere Technologies Inc. | Compositions for the delivery of antigens |
US20010003001A1 (en) * | 1993-04-22 | 2001-06-07 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5965121A (en) * | 1995-03-31 | 1999-10-12 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
CN1151836C (en) | 1995-03-31 | 2004-06-02 | 艾米斯菲尔技术有限公司 | Compound and compositions for delivering active agents |
US6001347A (en) * | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5989539A (en) * | 1995-03-31 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6090958A (en) * | 1995-03-31 | 2000-07-18 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
DE19514320A1 (en) * | 1995-04-18 | 1996-10-24 | Hoechst Ag | Polyamide foams |
US5820881A (en) * | 1995-04-28 | 1998-10-13 | Emisphere Technologies, Inc. | Microspheres of diamide-dicarboxylic acids |
US6051258A (en) * | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
US5667806A (en) * | 1995-06-07 | 1997-09-16 | Emisphere Technologies, Inc. | Spray drying method and apparatus |
US5750147A (en) * | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
US5824345A (en) * | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
DE19681560T1 (en) * | 1995-09-11 | 1998-08-20 | Emisphere Tech Inc | Process for the preparation of omega-aminoalkanoic acid derivatives from cycloalkanones |
US5879681A (en) * | 1997-02-07 | 1999-03-09 | Emisphere Technolgies Inc. | Compounds and compositions for delivering active agents |
US5776888A (en) * | 1997-02-07 | 1998-07-07 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5876710A (en) * | 1997-02-07 | 1999-03-02 | Emisphere Technologies Inc. | Compounds and compositions for delivering active agents |
US6358504B1 (en) * | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5990166A (en) * | 1997-02-07 | 1999-11-23 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5939381A (en) * | 1997-02-07 | 1999-08-17 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6060513A (en) * | 1997-02-07 | 2000-05-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5804688A (en) * | 1997-02-07 | 1998-09-08 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6313088B1 (en) | 1997-02-07 | 2001-11-06 | Emisphere Technologies, Inc. | 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents |
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6051561A (en) * | 1997-02-07 | 2000-04-18 | Emisphere Technologies Inc. | Compounds and compositions for delivering active agents |
US5962710A (en) * | 1997-05-09 | 1999-10-05 | Emisphere Technologies, Inc. | Method of preparing salicyloylamino acids |
US6221917B1 (en) * | 1997-12-30 | 2001-04-24 | American Home Products Corporation | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
US6440929B1 (en) * | 1998-07-27 | 2002-08-27 | Emisphere Technologies, Inc. | Pulmonary delivery of active agents |
JP4675481B2 (en) * | 1998-07-27 | 2011-04-20 | エミスフェアー・テクノロジーズ・インク | Pulmonary delivery of active agents |
CN1338924A (en) * | 1999-01-08 | 2002-03-06 | 艾米斯菲尔技术有限公司 | Polymeric delivery agents and delivery agent compounds |
AU3357800A (en) * | 1999-02-05 | 2000-08-25 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides |
AU3378100A (en) | 1999-02-26 | 2000-09-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2001044199A1 (en) * | 1999-12-16 | 2001-06-21 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6384278B1 (en) * | 2000-02-04 | 2002-05-07 | Emisphere Technologies, Inc. | Boron-mediated amidation of carboxylic acids |
US6399796B2 (en) * | 2000-03-17 | 2002-06-04 | Roche Vitamins Inc. | Activation of a Diels-Alder reaction of a sterol 5,7-diene |
-
1999
- 1999-08-06 EP EP99940967A patent/EP1102742B1/en not_active Expired - Lifetime
- 1999-08-06 ES ES99940967T patent/ES2267283T3/en not_active Expired - Lifetime
- 1999-08-06 CZ CZ20010449A patent/CZ302280B6/en not_active IP Right Cessation
- 1999-08-06 HU HU0103188A patent/HUP0103188A2/en unknown
- 1999-08-06 IL IL14093099A patent/IL140930A0/en active IP Right Grant
- 1999-08-06 CA CA002339765A patent/CA2339765C/en not_active Expired - Fee Related
- 1999-08-06 WO PCT/US1999/017974 patent/WO2000007979A2/en active IP Right Grant
- 1999-08-06 KR KR1020017001606A patent/KR100659753B1/en not_active IP Right Cessation
- 1999-08-06 TR TR2001/00366T patent/TR200100366T2/en unknown
- 1999-08-06 BR BR9912975-2A patent/BR9912975A/en not_active Application Discontinuation
- 1999-08-06 PL PL347671A patent/PL212652B1/en unknown
- 1999-08-06 AT AT99940967T patent/ATE329897T1/en not_active IP Right Cessation
- 1999-08-06 DE DE69931930T patent/DE69931930T2/en not_active Expired - Lifetime
- 1999-08-06 NZ NZ509410A patent/NZ509410A/en not_active IP Right Cessation
- 1999-08-06 AU AU54711/99A patent/AU5471199A/en not_active Abandoned
- 1999-08-06 CN CNB998094382A patent/CN1313439C/en not_active Expired - Fee Related
- 1999-08-06 JP JP2000563614A patent/JP4430235B2/en not_active Expired - Fee Related
-
2001
- 2001-01-16 IL IL140930A patent/IL140930A/en not_active IP Right Cessation
- 2001-11-14 HK HK01108027A patent/HK1036969A1/en not_active IP Right Cessation
-
2005
- 2005-06-30 US US11/173,075 patent/US7186414B2/en not_active Expired - Fee Related
-
2006
- 2006-09-13 US US11/531,602 patent/US7744910B2/en not_active Expired - Fee Related
-
2009
- 2009-10-27 JP JP2009246615A patent/JP5330190B2/en not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012475A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Active agent transport systems |
WO1996012473A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1996012474A1 (en) * | 1994-10-25 | 1996-05-02 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
WO1996021464A1 (en) * | 1995-01-13 | 1996-07-18 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
WO1996030036A1 (en) * | 1995-03-31 | 1996-10-03 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1997036480A1 (en) * | 1996-03-29 | 1997-10-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1998021951A1 (en) * | 1996-11-18 | 1998-05-28 | Emisphere Technologies, Inc. | Methods and compositions for inducing oral tolerance in mammals |
WO1998034632A1 (en) * | 1997-02-07 | 1998-08-13 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1998049135A1 (en) * | 1997-04-30 | 1998-11-05 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO1999016427A1 (en) * | 1997-09-29 | 1999-04-08 | Emisphere Technologies, Inc. | Active agent transport systems |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8927015B2 (en) | 2006-04-12 | 2015-01-06 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
US9364502B2 (en) | 2006-06-28 | 2016-06-14 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
US9119835B2 (en) | 2007-03-13 | 2015-09-01 | JDS Therapeautics, LLC | Methods and compositions for the sustained release of chromium |
US9597404B2 (en) | 2007-03-13 | 2017-03-21 | Jds Therapeutics, Llc | Methods and compositions for sustained release of chromium |
US9421170B2 (en) | 2007-06-26 | 2016-08-23 | Jds Therapeutics, Llc | Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
US11850308B2 (en) | 2007-06-26 | 2023-12-26 | Bonafide Health, Llc | Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
US8933022B2 (en) | 2011-03-01 | 2015-01-13 | Jds Therapeutics, Llc | Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
Also Published As
Publication number | Publication date |
---|---|
AU5471199A (en) | 2000-02-28 |
US20050272638A1 (en) | 2005-12-08 |
CN1313439C (en) | 2007-05-02 |
WO2000007979A2 (en) | 2000-02-17 |
ATE329897T1 (en) | 2006-07-15 |
JP2010024236A (en) | 2010-02-04 |
HUP0103188A2 (en) | 2001-12-28 |
JP5330190B2 (en) | 2013-10-30 |
CA2339765A1 (en) | 2000-02-17 |
BR9912975A (en) | 2001-09-25 |
KR100659753B1 (en) | 2006-12-20 |
US7186414B2 (en) | 2007-03-06 |
HK1036969A1 (en) | 2002-01-25 |
PL212652B1 (en) | 2012-11-30 |
CA2339765C (en) | 2009-04-28 |
DE69931930D1 (en) | 2006-07-27 |
IL140930A (en) | 2006-07-05 |
NZ509410A (en) | 2003-08-29 |
KR20010072308A (en) | 2001-07-31 |
IL140930A0 (en) | 2002-02-10 |
PL347671A1 (en) | 2002-04-22 |
EP1102742A2 (en) | 2001-05-30 |
CZ2001449A3 (en) | 2001-10-17 |
JP4430235B2 (en) | 2010-03-10 |
ES2267283T3 (en) | 2007-03-01 |
CN1315936A (en) | 2001-10-03 |
US20070010422A1 (en) | 2007-01-11 |
CZ302280B6 (en) | 2011-01-26 |
TR200100366T2 (en) | 2001-11-21 |
JP2002522413A (en) | 2002-07-23 |
US7744910B2 (en) | 2010-06-29 |
DE69931930T2 (en) | 2006-10-05 |
EP1102742B1 (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
MXPA01008611A (en) | Compounds and compositions for delivering active agents. | |
CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
IL153297A0 (en) | Compounds and compositions for delivering active agents | |
EP0993831A3 (en) | Compounds and compositions for delivering active agents | |
WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
WO2001032596A8 (en) | Phenoxy carboxylic acid compounds and compositions for delivering active agents | |
CA2360220A1 (en) | Oxadiazole compounds and compositions for delivering active agents | |
WO2003045306A3 (en) | Phenoxy amine compounds and compositions for delivering active agents | |
WO2002070438A3 (en) | Compositions for delivering bisphosphonates | |
CA2203033A1 (en) | Compounds and compositions for delivering active agents | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
EP2308479A3 (en) | Compounds and compositions for delivering active agents | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
WO2001005355A3 (en) | Formulations for il-11 | |
WO2002100338A3 (en) | Compound and composition for delivering active agents | |
WO2005062874A3 (en) | Compounds and compositions for delivering active agents | |
EP1676832A3 (en) | Compounds and compositions for delivering active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99809438.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 140930 Country of ref document: IL Ref document number: 509410 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/00470 Country of ref document: ZA Ref document number: 200100470 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 1999US 9917974 Country of ref document: KE Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999US9917974 Country of ref document: KE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 54711/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999940967 Country of ref document: EP Ref document number: PA/a/2001/001243 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-449 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 2339765 Country of ref document: CA Ref document number: 2339765 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017001606 Country of ref document: KR Ref document number: 2001/00366 Country of ref document: TR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999940967 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017001606 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09762067 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-449 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999940967 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1020017001606 Country of ref document: KR |